Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 Mont-Saint-Guibert, Belgium – October 22, 2024, 10:30pm CET / 4:30pm ET – Nyxoah
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds
Unbelievable Jeff! IriusRisk introduces an AI-powered tool which can generate threat models from images
The threat modeling platform launches ‘Jeff: AI Assistant’, a world first in terms of creating threat models through language and images. The new feature is
Quantexa Recognized as Category Leader in the RiskTech Quadrant® for KYC Solutions
Quantexa earned a top ranking in the RiskTech100® 2025 Report, highlighting its strength and innovation in the expanding risk technology and compliance market LONDON, Oct.
WGO INVESTOR NEWS: Winnebago Industries, Inc. Investors that Suffered Losses Are Encouraged to Contact RLF About Ongoing Investigation into the Company (NYSE: WGO)
NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on
FLUX INVESTOR NEWS: Flux Power Holdings, Inc. Investors that Suffered Losses are Encouraged to Contact RLF About Ongoing Investigation into the Company (NASDAQ: FLUX)
NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on